2023
DOI: 10.1002/ccr3.7237
|View full text |Cite
|
Sign up to set email alerts
|

Belly dancer syndrome improved by withdrawal of droxidopa and amantadine

Abstract: A man hospitalized for cerebral infarction developed drug-induced belly dancer syndrome, which improved after withdrawal of droxidopa and amantadine.Drugs that modulate dopamine neurotransmission have been reported to be associated with this syndrome. When belly dancer syndrome is suspected, clinicians should consider drug-induced abdominal dyskinesia and medication withdrawal.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Several cases indicate that discontinuation of the medications implicated in BDD leads to symptom resolution. In 2023, Kaga et al reported a case where cessation of droxidopa and amantadine entirely terminated abdominal movements [5]. Similarly, Wong et al's 2021 report documented symptom amelioration following cessation of salbutamol [6].…”
Section: Literature Reviewmentioning
confidence: 99%
“…Several cases indicate that discontinuation of the medications implicated in BDD leads to symptom resolution. In 2023, Kaga et al reported a case where cessation of droxidopa and amantadine entirely terminated abdominal movements [5]. Similarly, Wong et al's 2021 report documented symptom amelioration following cessation of salbutamol [6].…”
Section: Literature Reviewmentioning
confidence: 99%